Overview
| Acronym |
WGHS |
|---|---|
| Investigators | |
| Contacts | |
| Start Year | 2006 |
Study Design
| Study Design | Cohort |
|---|---|
| General Information on Follow Up (profile, frequency) |
Ongoing DNA analyses from the participants' blood sample provided at baseline (1992-1995) of the WHS study. |
| Recruitment Target |
|
| Number of Participants |
28,345 |
| Number of Participants with Biosamples |
28,345 |
Access
| Possible Access to Data |
|
| Possible Access to Biosamples |
|
| Other |
Marker Paper
Ridker PM, Chasman DI, Zee RY, Parker A, et al. Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. Clinical Chemistry, 2008; 54(2): 249-55.
Study Timeline
Each colour in the timeline graph below represents a separate Study Population, while each segment in the graph represents a separate Data Collection Event. Clicking on a segment gives more detailed information on a Data Collection Event.
Population
WGHS population
The cohort is composed of participants of the WHS study. The WHS included initially healthy American women, aged 45 years and older, with no previous history of cardiovascular disease, cancer or other major chronic illnesses at baseline in 1992-1995.
Sources of Recruitment
| Participants from Existing Studies | Women's Health Study |
|---|---|
| Supplementary Information | All members of the WGHS cohort were participants in the WHS who provided an adequate baseline blood sample for plasma and DNA analysis and who gave consent for blood-based analyses and long-term follow-up. |
Selection Criteria
| Gender | Women only |
|---|---|
| Age | Minimum age 45 |
| Country | United States of America |
Sample Size
| Number of Participants |
28,345 |
|---|---|
| Number of Participants with Biosamples |
28,345 |
Data Collection Events
| Name | Description | Start | End |
|---|---|---|---|
| WGHS analyses | Because each WGHS participant is also a WHS... | 2006 (October) | 2014 (December) |
Mica